AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,272 | +27.0% | 14,274 | +2.0% | 0.00% | – |
| Q2 2023 | $12,810 | -36.0% | 14,000 | +591.4% | 0.00% | – |
| Q2 2018 | $20,000 | -4.8% | 2,025 | -9.7% | 0.00% | – |
| Q1 2018 | $21,000 | -40.0% | 2,242 | -4.6% | 0.00% | – |
| Q4 2017 | $35,000 | -14.6% | 2,351 | +11.5% | 0.00% | – |
| Q3 2017 | $41,000 | +46.4% | 2,108 | +6.8% | 0.00% | – |
| Q2 2017 | $28,000 | +55.6% | 1,974 | -0.8% | 0.00% | – |
| Q1 2017 | $18,000 | +50.0% | 1,989 | +77.4% | 0.00% | – |
| Q4 2016 | $12,000 | -25.0% | 1,121 | -36.6% | 0.00% | – |
| Q3 2016 | $16,000 | +6.7% | 1,768 | -9.2% | 0.00% | – |
| Q2 2016 | $15,000 | -28.6% | 1,947 | -17.7% | 0.00% | – |
| Q1 2016 | $21,000 | -43.2% | 2,367 | -17.7% | 0.00% | – |
| Q4 2015 | $37,000 | – | 2,877 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |